BIOINDUSTRY · BY-PRODUCT VALORISATION

Plant-derived extracellular vesicles

Fruits, leaves, roots and plant cell cultures release extracellular vesicles: membrane nanoparticles carrying the plant’s lipids, proteins and metabolites. They are of interest as actives and as carriers, but for plant vesicles there are no harmonised quality criteria yet. The matrix is often a by-product of plant processing, and obtaining them takes enzyme-assisted extraction, purification, characterisation and formulation in one path. In the end, characterisation is what makes the difference.

Let us talk about your matrix
WHERE IT STARTS

Three different questions

Which question it is decides where the work concentrates: on the matrix, on the isolated material or on the active to be carried.

You have a plant matrix

What vesicle yield does it give, and how do you make it reproducible from batch to batch? It starts from choosing and preparing the matrix: juice, extract, cell culture or by-product.

You have an isolated preparation

Is it pure, is it stable, is its size distribution consistent across batches? It starts from characterisation.

You want to use them as carriers

How much active can you load, and does the target cell receive it? It starts from loading and the test on the target cell.

The path

Six stages, activated depending on the starting point.

Stage one

Matrix

Choice and preparation of the plant matrix, by-products included; homogenisation, enzyme-assisted extraction, clarification.

Stage two

Isolation and purification

Differential centrifugation, concentration and diafiltration by tangential flow filtration (TFF), size-exclusion chromatography (SEC).

Stage three

Characterisation

Particle concentration and size distribution by NTA; protein and lipid content; matrix contaminants.

Proof of vesicular nature by repeating NTA after membrane disruption, comparison with a process blank, spike recovery and mass balance. Go criteria declared before starting; then development on the pilot membrane-filtration plant.

Stage four

Stability and format

Stabilised powder or dispersion; real-time and accelerated stability.

Stage five

Biological activity

Effect on keratinocytes, fibroblasts, intestinal epithelium and 3D models; uptake by the target cell.

Stage six

Delivery

Loading of an active, encapsulation efficiency, release and delivery to the target cell.

What we measure

The numbers that tell whether a vesicle preparation is a reproducible material.

  • — particles per mL and size distribution, by NTA
  • — yield per amount of matrix
  • — protein and lipid content
  • — matrix contaminants left after purification
  • — stability of size and concentration over time
  • — batch-to-batch consistency
  • — uptake by target cells
  • — encapsulation efficiency and release of the active

The laboratory behind it

Equipment

IsolationDifferential centrifugation, tangential flow filtration (TFF)
PurificationSize-exclusion chromatography on ÄKTA systems
CharacterisationNanoparticle tracking analysis (NTA)
FormatFreeze-drying and stabilisation as powder
BiologyCell cultures and reconstructed 3D tissues

What you take home

ProtocolA written, transferable isolation method
DataSize, concentration and purity per batch
StabilityBehaviour over time under the chosen conditions
ActivityResults on cell models, with controls

Start with the matrix

Tell us which plant or by-product you start from and what the vesicle has to do: the first step is to find out whether the matrix yields enough of them.

Let us talk about your matrix

Tell us about your project

Write to us here: the division team will get back to you.